BNGOBionano Genomics, Inc.

Nasdaq bionanogenomics.com


$ 0.97 $ 0.05 (5.43 %)    

Thursday, 09-May-2024 15:59:52 EDT
QQQ $ 441.40 $ 1.34 (0.3 %)
DIA $ 394.43 $ 3.95 (1.01 %)
SPY $ 520.56 $ 3.37 (0.65 %)
TLT $ 90.69 $ 0.50 (0.55 %)
GLD $ 216.93 $ 3.35 (1.57 %)
$ 0.92
$ 0.95
$ 0.00 x 0
$ 0.00 x 0
$ 0.94 - $ 1.00
$ 0.71 - $ 8.20
1,282,241
na
48.52M
$ 2.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-05-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-23-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 06-18-2020 03-31-2020 10-Q
18 03-10-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-14-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bionano-genomics-q1-2024-gaap-eps-060-beats-065-estimate-sales-8769m-beat-8492m-estimate

Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0....

 bionano-announces-publication-showing-ogms-high-resolution-structural-variation-detection-in-cancer-validated-by-cas9-directed-nanopore-sequencing

Bionano Genomics, Inc. (NASDAQ:BNGO), today announced the results of an implementation study conducted by researchers at Univer...

 bionano-announces-publication-showing-that-ogm-detects-over-1250-structural-variants-including-56-gene-fusions-in-pediatric-leukemia-that-were-missed-by-whole-genome-sequencing

Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study from Penn State College of Medicine that used o...

 bionano-announces-publication-of-a-breast-cancer-study-showing-that-the-number-of-svs-detected-with-ogm-may-be-related-to-prognosis-tumor-progression-and-chemotherapy-resistance

Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study of optical genome mapping (OGM) in hereditary b...

 scotiabank-maintains-sector-outperform-on-bionano-genomics-lowers-price-target-to-6

Scotiabank analyst Sung Ji Nam maintains Bionano Genomics (NASDAQ:BNGO) with a Sector Outperform and lowers the price target...

 bionano-genomics-sees-q1-revenue-825m-875m-vs-969m-est-fy24-revenue-37m-41m-vs-4717m-est

2024 OutlookWe remain hyper focused on our mission of transforming the way the world sees the genome. To that end we want to hi...

 bionano-genomics-q4-sales-10721m-beat-10585m-estimate

Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $10.721 million which beat the analyst consensus estimate of $10.585...

 earnings-scheduled-for-march-5-2024

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2...

 bionano-publishes-interim-readout-from-second-phase-of-clinical-trial-analyzing-optical-genome-mapping-as-standard-of-care-for-prenatal-testing

Pre-print publication from Levy, et al. describes the second phase of a multisite evaluation and validation of optical genome m...

 bionano-announces-full-commercial-release-of-the-stratys-system-for-high-throughput-optical-genome-mapping

Bionano has completed the early access program for the Stratys™ system and is now making it available in a full commercial rele...

 bionano-announces-peer-reviewed-publication-from-its-clinical-study-designed-to-support-ogm-as-part-of-standard-of-care-in-genetic-disease-testing

Peer-reviewed publication from Broeckel, et al. describes the second phase of a multisite evaluation of optical genome mapping ...

 bionano-reports-preliminary-q4-and-fy23-results-sees-q4-revenue-104m-107m-vs-1054m-est-fy23-revenue-358m-361m-vs-3594m-est-achieved-all-full-year-2023-elevate-milestones

Preliminary Q4 2023 revenue expected to be between $10.4 and $10.7 million, which would represent an estimated increase of 27% ...

 bionano-laboratories-announced-the-publication-of-the-first-framework-paper-for-the-clinical-adoption-and-implementation-of-the-optical-genome-mapping-workflow-for-hematological-malignancy-applications

Framework was co-authored by an international consortium made up of 18 cancer researchersPublication includes researchers' ...

 bionano-announces-publication-of-largest-prospective-prenatal-study-comparing-ogm-to-chromosomal-microarray-analysis-and-karyotyping

Key findings from prospective evaluation of 200 prenatal samples:   Optical genome mapping (OGM) detected pathogenic structu...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION